A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients

Authors :: de Wet, N.
Llanos-Cuentas, A.
Suleiman, J.
Baraldi, E.
Krantz, E.F.
Negra, M. Della
Diekmann-Berndt, H.
Source :: Clinical Infectious Diseases. Sept 15, 2004, Vol. 39 Issue 6, p842, 8 p.
Publication Year :: 2004

Subjects :: HIV patients -- Drug therapy
Antifungal agents -- Dosage and administration
Antifungal agents -- Research
Candidiasis -- Drug therapy
Health
Health care industry

Tools